SCA
GILD icon

Sassicaia Capital Advisers’s Gilead Sciences GILD Stock Holding History

Sassicaia Capital Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,000
Closed -$816K – 71
2020
Q4 		$816K Buy
+14,000
New +$845K 1.69% 16

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sassicaia Capital Advisers's GILD Position: Q1 2021 in Review

Sassicaia Capital Advisers sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 14,000 shares — an estimated $816K sold.

Sassicaia Capital Advisers first reported a position in GILD in Q4 2020 and held it in 1 quarter. The position peaked at $816K in Q4 2020. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Sassicaia Capital Advisers reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 14,000 Gilead Sciences shares in Q1 2021, an estimated $816K.
  • Sassicaia Capital Advisers first reported a position in Gilead Sciences in Q4 2020 and held it in 1 quarter.
  • Sassicaia Capital Advisers's Gilead Sciences position peaked at $816K in Q4 2020.
  • 1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Sassicaia Capital Advisers's 13F filing for Q1 2021, filed 17 May 2021.